BRACONI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 6.014
EU - Europa 5.553
AS - Asia 740
OC - Oceania 12
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 8
Totale 12.344
Nazione #
US - Stati Uniti d'America 5.999
GB - Regno Unito 1.860
IT - Italia 874
IE - Irlanda 792
CN - Cina 539
SE - Svezia 468
DE - Germania 461
UA - Ucraina 418
FR - Francia 260
FI - Finlandia 147
RU - Federazione Russa 110
SG - Singapore 68
TR - Turchia 46
ES - Italia 40
BE - Belgio 30
CZ - Repubblica Ceca 26
IN - India 23
IR - Iran 22
NL - Olanda 17
VN - Vietnam 16
AT - Austria 15
CA - Canada 12
AU - Australia 9
PK - Pakistan 8
EU - Europa 7
JP - Giappone 6
SK - Slovacchia (Repubblica Slovacca) 6
PT - Portogallo 5
HU - Ungheria 4
PL - Polonia 4
RO - Romania 4
DK - Danimarca 3
GR - Grecia 3
JO - Giordania 3
MX - Messico 3
NZ - Nuova Zelanda 3
PE - Perù 3
SA - Arabia Saudita 3
AR - Argentina 2
BG - Bulgaria 2
EG - Egitto 2
SO - Somalia 2
TN - Tunisia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BO - Bolivia 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
HK - Hong Kong 1
IL - Israele 1
IM - Isola di Man 1
LB - Libano 1
MT - Malta 1
NG - Nigeria 1
PH - Filippine 1
TH - Thailandia 1
Totale 12.344
Città #
Southend 1.712
Fairfield 878
Dublin 782
Menlo Park 730
Chandler 553
Ashburn 422
Woodbridge 400
Jacksonville 347
Siena 347
Wilmington 331
Seattle 299
Houston 293
Cambridge 276
Ann Arbor 238
Princeton 164
Nanjing 116
Beijing 115
Helsinki 83
Boardman 75
San Mateo 59
Florence 58
New York 58
Dearborn 46
Shanghai 46
Fremont 45
Nanchang 43
Singapore 43
San Diego 42
Milan 39
Izmir 38
Lancaster 33
Shenyang 30
Brussels 28
Málaga 28
Moscow 24
Rome 24
Hebei 22
London 22
Redwood City 21
Brno 20
Norwalk 19
Tianjin 19
Changsha 18
Jiaxing 18
Dong Ket 16
Los Angeles 16
Munich 16
Kunming 15
Renton 15
Vienna 14
Monteroni D'arbia 12
Zhengzhou 12
Curtarolo 11
Düsseldorf 11
University Park 11
Washington 11
Nürnberg 9
Delhi 8
Guangzhou 8
Hangzhou 8
Verona 8
Jinan 7
San Francisco 7
Stockholm 7
Taizhou 7
Toronto 7
Eboli 6
Hefei 6
Ningbo 6
Olomouc 6
Pisa 6
Prato 6
Venezia 6
Borgo San Lorenzo 5
Bratislava 5
Castelfiorentino 5
Faisalabad 5
Kilburn 5
Sacramento 5
Tappahannock 5
Zanjan 5
Bonndorf 4
Canberra 4
Changchun 4
Floral Park 4
Groningen 4
Grosseto 4
Haikou 4
Hanover 4
Kocaeli 4
Leawood 4
Lisbon 4
Pewaukee 4
Prescot 4
Redmond 4
Anguillara Sabazia 3
Atlanta 3
Auburn Hills 3
Auckland 3
Bangalore 3
Totale 9.393
Nome #
Chondroptosis in alkaptonuric cartilage 324
Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria 280
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 265
Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria 260
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 240
Amyloidosis, Inflammation, and Oxidative Stress in the Heart of an Alkaptonuric Patient. 228
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 226
Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project 222
Beer promotes differentiation and mineralization of human osteoblastic cells: Role of silicon 214
Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins 213
4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases 208
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 208
Biochemical and proteomic characterization of alkaptonuric chondrocytes 207
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure 204
Oxidative stress and mechanisms of ochronosis in alkaptonuria 196
Alkaptonuria is a novel human secondary amyloidogenic disease 188
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. 185
Diagnosis of secondary amyloidosis in alkaptonuria 181
Effects of selenium on oxidative damage and antioxidant enzymes of eukaryotic cells: wine Saccharomyces cerevisiae 181
Secondary amyloidosis in an alkaptonuric aortic valve 180
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 180
Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria 175
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 172
Foodomics for human health: current status and perspectives 171
Angiogenesis in alkaptonuria 168
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes 166
Suitability of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment 165
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis 164
Wild-type wine Saccharomyces cerevisiae as a tool to evaluate the effects on eukaryotic life of locally used herbicides 163
An Introduction to Personalized Nutrition 162
Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease 161
Machine learning application for patient stratification and phenotype/genotype investigation in a rare disease 161
Prevalence of isolated atrial amyloidosis in young patients affected by congestive heart failure 158
Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease 158
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria 155
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis 154
Helicobacter pylori: immunoproteomics related to different pathologies 152
Saccharomyces cerevisiae as a Tool to Evaluate the Effects of Herbicides on Eukaryotic Life 152
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain 150
Post-genomics of bone metabolic dysfunctions and neoplasias 147
Yield Determination of Bioethanol Production of Saccharomyces Cerevisiae Metabolic Process by Mathematical Modelling and In-Vivo 13C-NMR 146
Amyloidosis in alkaptonuria 143
Comparative analysis of the effects of locally used herbicides and their active ingredients on a wild-type wine Saccharomyces cerevisiae strain 139
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model 139
Saccharomyces cerevisiae as a model in ecotoxicological studies: a post-genomics perspective 138
Surfome analysis of a wild-type wine Saccharomyces cerevisiae strain 137
Redox proteomics gives insights into the role of oxidative stress in alkaptonuria. 137
Mapping phosphoproteins in Neisseria meningitidis serogroup A 136
Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria 134
Metabolic response to exogenous ethanol in yeast: an in vivo NMR and mathematical modelling approach 133
Oxidative damage induced by herbicides is mediated by thiol oxidation and hydroperoxides production 131
Oxidative damage mediated by herbicides on yeast cells 130
Linking protein oxidation to environmental pollutants: redox proteomic approaches 130
Membrane Skeletal Protein S-Glutathionylation in Human Red Blood Cells as Index of Oxidative Stress 130
In vivo NMR study of yeast fermentative metabolism in the presence of ferric irons 127
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial 127
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. 127
Personalized nutrition and omics technologies 126
Omics-based technologies for food authentication and traceability 123
Post-genomics and skin inflammation 118
Cell and tissue models of alkaptonuria 117
Postgenomics of Neisseria meningitidis: An update 116
Omics Perspectives in Food Science 116
Supportive use of cyclodextrins as decontamination agents for herbicides 112
Expanding the proteome database of Meningococcus A 107
Antibacterial activity of grape extracts towards cagA positive and cagA negative Helicobacter pylori clinical isolates 104
Rubus ulmifolius Leaf Extract Inhibits Proliferation of Murine Myeloma Cells 102
The therapy for Helicobacter pylori eradication 100
Sub-lethal ethanol exposure enhances viability and ethanol production in Saccharomyces cerevisiae 98
Diagnosis of Helicobacter pylori infection 94
The analysis of Neisseria meningitidis proteomes: reference maps and their applications 93
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria 89
Identification of Helicobacter pylori proteins involved in metronidazole resistance by comparative proteomic analysis 84
Bacterial post-genomics approaches for vaccines development 84
Leveraging proteomics in orphan disease research: pitfalls and potential 82
Post-genomics of Neisseria meningitidis: an update 81
Postgenomics of Neisseria meningitidis for vaccines development 80
Novel identification of expressed genes and functional classification of hypothetical proteins from Neisseria meningitidis serogroup A 77
Subclinical ochronosis features in alkaptonuria: a cross-sectional study 73
Proteomics in plant research 72
Models of rare diseases 68
Helicobacter pylori infection and extra-digestive diseases 62
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies 61
Helicobacter pylori VacA and CagA virulence factors 61
Kinetics of different processes in human ANP amyloid formation 58
Survey on the recent advances in 4-Hydroxyphenylpyruvate Dioxygenase (HPPD) inhibition by diketone and triketone derivatives and congeneric compounds: structural analysis of HPPD/inhibitor complexes and structure-activity relationship considerations 56
Alkaptonuria 24
Alkaptonuria: From Molecular Insights to a Dedicated Digital Platform 4
Totale 12.570
Categoria #
all - tutte 35.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.093 0 96 150 338 174 185 209 286 212 192 83 168
2020/20212.098 98 153 84 224 169 219 98 262 185 331 156 119
2021/20221.586 139 173 118 121 77 62 83 60 86 193 161 313
2022/20231.822 117 188 236 249 167 340 61 155 167 43 54 45
2023/20241.357 47 30 126 65 66 361 427 38 5 14 48 130
2024/2025150 64 86 0 0 0 0 0 0 0 0 0 0
Totale 12.570